CFT-PET brain imaging was used to observe the distribution of DAT in different regions of the brain, revealing a significantly reduced distribution of DAT in the bilateral SN striatum and hippocampus regions of the PD group, indicating impaired dopaminergic neuron function (Additional file 1: Fig. S3d). This evidence concerns the gene SLC6A3 and Parkinson disease.